Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation

American Journal of Transplantation

Volumn 6, Issue 1, 2006, Pages 205-208

  Kohnle, M ^a   Pietruck, F ^a   Kribben, A ^a   Philipp, Th ^a   Heemann, U ^b   Witzke, O ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ezetimibe; Hypercholesterolemia; Renal transplantation

Indexed keywords

CREATINE KINASE; CREATININE; CYCLOSPORIN A; ELECTROLYTE; EZETIMIBE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MUSCLE ENZYME; TRIACYLGLYCEROL; TSUKUBAENOLIDE; UREA; AZETIDINE DERIVATIVE; CHOLESTEROL; CYCLOSPORIN; HYPOCHOLESTEROLEMIC AGENT; INDOLE DERIVATIVE; MONOUNSATURATED FATTY ACID; PRAVASTATIN; SIMVASTATIN; TACROLIMUS;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG SAFETY; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MYALGIA; NAUSEA; PRIORITY JOURNAL; TIME SERIES ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; ADULT; AGED; BLOOD; CLINICAL TRIAL; DRUG COMBINATION; ENZYMOLOGY; FEMALE; LIVER; MALE; MIDDLE AGED; SKELETAL MUSCLE;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INDOLES; KIDNEY TRANSPLANTATION; LIVER; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PRAVASTATIN; SIMVASTATIN; TACROLIMUS;

EID: 33644869165     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01132.x     Document Type: Article

References (21)

1. Briggs JD Causes of death after renal transplantation Nephrol Dial Transplant 2001 16 1545 1549
2. Kasiske BL Cardiovascular disease after renal transplantation Semin Nephrol 2000 20 176 187
3. Lindholm A Albrechtsen D Frodin L Tufveson G Persson NH Lundgren G Ischemic heart disease - major cause of death and graft loss after renal transplantation in Scandinavia Transplantation 1995 60 451 457
4. Hamar P Muller V Kohnle M et al Metabolic factors have a major impact on kidney allograft survival Transplantation 1997 64 1135 1139
5. Roodnat JI Mulder PG Zietse R et al Cholesterol as an independent predictor of outcome after renal transplantation Transplantation 2000 69 1704 1710
6. Holdaas H Fellstrom B Jardine AG et al. Assessment of lescol in Renal Transplantation (ALERT) Study Investigators Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet 2003 361 2024 2031
7. Jardine AG Holdaas H Fellstrom B et al. ALERT Study Investigators Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study Am J Transplant 2004 4 988 995
8. Cosio FG Pesavento TE Pelletier RP et al Patient survival after renal transplantation III: the effects of statins Am J Kidney Dis 2002 40 638 643
9. Smith S Blair S Bonow R et al AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 2001 104 1577 1579
10. Pearson TA Blair SN Daniels SR et al AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee Circulation 2002 106 388 391
11. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 2001 285 2486 2497
12. Kiberd B Keough-Ryan T Panek R Cardiovascular disease reduction in the outpatient kidney transplant clinic Am J Transplant 2003 3 1393 1399
13. Kasiske B Cosio FG Beto J et al National Kidney Foundation Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative Am J Transplant 2004 4 13 53
14. Chmielewski M Zdrojewski Z Rutkowski B Benefits and menaces related to the use of statins in patients after renal transplantation Ann Transplant 2002 7 6 10
15. Sudhop T Lutjohann D Kodal A et al Inhibition of intestinal cholesterol absorption by ezetimibe in humans Circulation 2002 106 1943 1948
16. Ballantyne CM Houri J Notarbartolo A et al Ezetimibe Study Group Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial Circulation 2003 107 2409 2415
17. Puthenparumpil JJ Keough-Ryan T Kiberd M Lawen J Kiberd BA Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population Transplant Proc 2005 37 1033 1035
18. Koshman SL Lalonde LD Burton I Tymchak WJ Pearson GJ Supratherapeutic response to ezetimibe administered with cyclosporine (September) Ann Pharmacother 2005 Epub ahead of print
19. Davidson MH McGarry T Bettis R et al Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia J Am Coll Cardiol 2002 40 2135 2138
20. Kosoglou T Statkevich P Johnson-Levonas AO Paolini JF Bergman AJ Alton KB Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions Clin Pharmacokinet 2005 44 467 494
21. García Calvo M Lisnock J Bull HG et al The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1) Proc Natl Acad Sci U S A 2005 102 8132 8127